[1] Caballero B. Humans against obesity: who will win?[J]. Ado Nutr, 2019, 10: S4-S9.
[2] 马依彤,刘帅. 肥胖与心血管疾病的研究进展[J]. 新疆医科大学学报, 2021, 44(10): 1111-3.
[3] Kalupahana N S, Moustaid-Moussa N. Beyond blood pressure, fluid and electrolyte homeostasis—role of the renin angiotensin aldosterone system in the interplay between metabolic diseases and breast cancer[J]. Acta Physiol, 2024, 240(7): e14164.
[4] Cao X, Song L N, Yang J K. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders[J]. Clin Sci (Lond), 2021, 135(3): 535-554.
[5] Wang R X, Ye H W, Zhao Y T, et al. Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials[J]. BMC Med, 2022, 20(1): 487.
[6] Wang J, Li D, Zhang Y, et al. Angiotensin Ⅱ type 1a receptor knockout ameliorates high-fat diet-induced cardiac dysfunction by regulating glucose and lipid metabolism[J]. Acta Biochim Biophys Sin (Shanghai), 2023,55(9):1380-1392.
[7] Rodriguez R, Lee A Y, Godoy-Lugo J A, et al. Chronic AT1 blockade improves hyperglycemia by decreasing adipocyte inflammation and decreasing hepatic PCK1 and G6PC1 expression in obese rats[J]. Am J Physiol Endocrinol Metab, 2021, 321(5): e714-e727.
[8] Villarroya F, Cereijo R, Villarroya J, et al. Brown adipose tissue as a secretory organ[J]. Nat Rev Endocrinol, 2017, 13(1): 26-35.
[9] Gorzelniak K, Engeli S, Janke J, et al. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension[J]. J Hypertens, 2002, 20(5): 965-973.
[10] Kurata A, Nishizawa H, Kihara S, et al. Blockade of angiotensin Ⅱ type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation[J]. Kidney Int, 2006, 70(10): 1717-1724.
[11] Aksoy H, Karadag A S, Wollina U. Angiotensin Ⅱ receptors: impact for COVID-19 severity[J]. Dermatol Ther, 2020, 33(6): e13989.
[12] Carlsson P O, Berne C, Jansson L. Angiotensin Ⅱ and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats[J]. Diabetologia, 1998, 41(2): 127-133.
[13] Grace J A, Herath C B, Mak K Y, et al. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options[J]. Clin Sci, 2012, 123(4): 225-239.
[14] Frantz E D C, Prodel E, Braz I D, et al. Modulation of the renin-angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training[J]. Clin Sci, 2018, 132(14): 1487-1507.
[15] Gutierrez-Rodelo C, Arellano-Plancarte A, Hernandez-Aranda J, et al. Angiotensin Ⅱ inhibits insulin receptor signaling in adipose cells[J]. Int J Mol Sci, 2022, 23(11): 6048.
[16] Silva-Velasco DL, Cervantes-Pérez LG, Sánchez-Mendoza A. ACE inhibitors and their interaction with systems and molecules involved in metabolism[J]. Heliyon, 2024, 10(2): e24655.
[17] Abd-Eltawab Tammam A, Rizg W Y, Fakhry Boushra A, et al. Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model[J]. Front Pharmacol, 2023, 14: 1228525.
[18] 倪程佩, 王婧怡, 沈艳华, 等. 自发与诱发2型糖尿病小鼠模型的比较研究[J]. 中国比较医学杂志, 2016, 26(9): 36-41, 49.
[19] Danser A H J, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers[J]. Hypertension, 2020, 75(6): 1382-1385.
[20] Xuan X, Gao F, Ma X, et al. Activation of ACE2/angiotensin (1-7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model[J]. Metabolism, 2018, 81:83-96.
[21] Cao X, Lu X M, Tuo X, et al. Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism[J]. Lipids Health Dis, 2019, 18(1): 207.
[22] Cao X, Song L N, Zhang Y C, et al. Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease[J]. Diabetes Metab Res Rev, 2019, 35(4): e3123.
[23] Pahlavani M, Kalupahana N S, Ramalingam L, et al. Regulation and functions of the renin-angiotensin system in white and brown adipose tissue[J]. Compr Physiol, 2017, 7(4): 1137-1150.
[24] Than A, Leow M K S, Chen P. Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin Ⅱ/AT1 receptor signaling pathways[J]. J Biol Chem, 2013, 288(22): 15520-15531.
[25] Guan L L, Gong D Z, Yang S R, et al. Genipin ameliorates diet-induced obesity via promoting lipid mobilization and browning of white adipose tissue in rats[J]. Phytother Res, 2018, 32(4): 723-732.
[26] Cao X, Shi T T, Zhang C H, et al. ACE2 pathway regulates thermogenesis and energy metabolism[J]. Elife, 2022, 11: e72266.
|